Sumitomo Pharma America, Inc. (SMPA) today announced that it has enrolled the required number of participants in its pivotal Phase 2 monotherapy trial for enzomenib, an investigational, oral selective ...
APEX 24-week Phase 2 trial is evaluating the safety and efficacy of TX45 in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF)APEX Phase 2 ...
OpenAI is preparing what CNBC’s Joe Kernen, citing Financial Times reporting, called “The biggest update to ChatGPT since the ...
RRB NTPC UG 2026 Admit Card: The Railway Recruitment Board (RRB) has started releasing the RRB NTPC UG Admit Card for ...